An important future area for investigation will be to develop an Eμ-Myc model of acquired CHK1i resistance by reimplanting WT Eμ-Myc lymphoma cells and subjecting them to multiple rounds of CCT244747 treatment and recovery. This evidence concerns the gene MYC and lymphoma.